Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Seminars in Oncology Nursing
|
May 1, 2012
Oncology biomarkers: discovery, validation, and clinical use
Brandy M Heckman-Stoddard
Seminars in Oncology Nursing
|
May 6, 2014
Precision medicine clinical trials: defining new treatment strategies
Brandy M Heckman-Stoddard, Judith J Smith
Diabetologia
|
August 5, 2017
Repurposing metformin for the prevention of cancer and cancer recurrence
Brandy M Heckman-Stoddard, Andrea DeCensi, Vikrant V Sahasrabuddhe, et al.
JNCI Cancer Spectrum
|
June 3, 2022
Time-Restricted Feeding Studies and Possible Human Benefit
Patrick Boyd, Sydney G O'Connor, Brandy M Heckman-Stoddard, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 5, 2019
Breast Cancer Characteristics and Survival among Users versus Nonusers of Raloxifene
Paul F Pinsky, Eric A Miller, Brandy M Heckman-Stoddard, et al.
Breast Cancer (Tokyo, Japan)
|
February 15, 2020
Breast cancer risk prediction models and subsequent tumor characteristics
Eric A Miller, Paul F Pinsky, Brandy M Heckman-Stoddard, et al.
Seminars in Oncology
|
March 13, 2016
Repurposing old drugs to chemoprevention: the case of metformin
Brandy M Heckman-Stoddard, Sara Gandini, Matteo Puntoni, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 3, 2022
Report from an NCI Roundtable: Cancer Prevention in Primary Care
Goli Samimi, Jasmine Douglas, Brandy M Heckman-Stoddard, et al.
Breast Cancer Research : BCR
|
October 31, 2012
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug
Matteo Lazzeroni, Davide Serrano, Barbara K Dunn, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 3, 2014
Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders
Sara Gandini, Matteo Puntoni, Brandy M Heckman-Stoddard, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Seminars in Oncology Nursing
|
May 1, 2012
Oncology biomarkers: discovery, validation, and clinical use
Brandy M Heckman-Stoddard
Seminars in Oncology Nursing
|
May 6, 2014
Precision medicine clinical trials: defining new treatment strategies
Brandy M Heckman-Stoddard, Judith J Smith
Diabetologia
|
August 5, 2017
Repurposing metformin for the prevention of cancer and cancer recurrence
Brandy M Heckman-Stoddard, Andrea DeCensi, Vikrant V Sahasrabuddhe, et al.
JNCI Cancer Spectrum
|
June 3, 2022
Time-Restricted Feeding Studies and Possible Human Benefit
Patrick Boyd, Sydney G O'Connor, Brandy M Heckman-Stoddard, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 5, 2019
Breast Cancer Characteristics and Survival among Users versus Nonusers of Raloxifene
Paul F Pinsky, Eric A Miller, Brandy M Heckman-Stoddard, et al.
Breast Cancer (Tokyo, Japan)
|
February 15, 2020
Breast cancer risk prediction models and subsequent tumor characteristics
Eric A Miller, Paul F Pinsky, Brandy M Heckman-Stoddard, et al.
Seminars in Oncology
|
March 13, 2016
Repurposing old drugs to chemoprevention: the case of metformin
Brandy M Heckman-Stoddard, Sara Gandini, Matteo Puntoni, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 3, 2022
Report from an NCI Roundtable: Cancer Prevention in Primary Care
Goli Samimi, Jasmine Douglas, Brandy M Heckman-Stoddard, et al.
Breast Cancer Research : BCR
|
October 31, 2012
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug
Matteo Lazzeroni, Davide Serrano, Barbara K Dunn, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 3, 2014
Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders
Sara Gandini, Matteo Puntoni, Brandy M Heckman-Stoddard, et al.
Page
of 5